MAML1 regulates EMT markers expression through NOTCH-independent pathway in breast cancer cell line MCF7.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
12 03 2019
Historique:
received: 29 12 2018
revised: 17 01 2019
accepted: 23 01 2019
pubmed: 9 2 2019
medline: 5 11 2019
entrez: 9 2 2019
Statut: ppublish

Résumé

Tumor relapse is the main cause of breast cancer related deaths and metastasis due to epithelial-mesenchymal transition (EMT) having a critical role in this process. MAML1 is the main co activator of NOTCH signaling pathway and its role in EMT remains unknown. In this study, this role was evaluated through overexpression and knockdown study of MAML1 in MCF7 and MDA-MB-231 cells. MAML1 overexpression up regulated the epithelial and down regulated the mesenchymal markers. In addition, MAML1 silencing decreased epithelial and increased mesenchymal markers. Notch inhibition using γ-secretase inhibitor resulted in increased E-cadherin expression. MAML1 ectopic expression, further increased E-cadherin expression with inhibition of NOTCH signaling. Wound healing assay showed that MAML1 overexpression decreases the rate of migration, while MAML1 silencing increases this rate significantly. In conclusion, our data indicated that MAML1 negatively regulates EMT markers expression in breast cancer cells.

Identifiants

pubmed: 30732857
pii: S0006-291X(19)30125-1
doi: 10.1016/j.bbrc.2019.01.101
pii:
doi:

Substances chimiques

Antigens, CD 0
Biomarkers 0
CDH1 protein, human 0
Cadherins 0
DNA-Binding Proteins 0
MAML1 protein, human 0
Receptors, Notch 0
Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

376-382

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Seyedeh Mahya Shariat Razavi (SM)

Department of Biology, University of Sistan and Baluchestan, Zahedan, Iran; Medical Genetics Research Center, Faculty of Medical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.

Mohammad Mahdi Forghanifard (MM)

Department of Biology, Damghan Branch, Islamic Azad University, Damghan, Iran.

Dor Mohammad Kordi-Tamandani (DM)

Department of Biology, University of Sistan and Baluchestan, Zahedan, Iran. Electronic address: dor_kordi@science.usb.ac.ir.

Mohammad Reza Abbaszadegan (MR)

Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: abbaszadeganmr@mums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH